Skip to main content

Each child born to a parent with HHT has a fifty percent chance of inheriting the disease. Children with HHT may not yet have nosebleeds or telangiectasia (red spots) but are still at risk for serious complications from lung and brain arteriovenous malformations. Early diagnosis and appropriate AVM screening for children is essential to help prevent complications such as stroke and low oxygen levels. Children should be evaluated by a health care provider with expert knowledge of HHT as early as possible.